Systematic Financial Management LP Jounce Therapeutics, Inc. Transaction History

Systematic Financial Management LP

  • $3.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$4.58 - $10.95 $166,093 - $397,101
-36,265 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$4.17 - $7.58 $83,358 - $151,524
-19,990 Reduced 35.53%
36,265 $250,000
Q1 2020

May 12, 2020
SELL
$2.91 - $8.7 $28,518 - $85,260
-9,800 Reduced 14.84%
56,255 $267,000
Q4 2019

Feb 14, 2020
BUY
$2.81 - $9.21 $185,614 - $608,366
66,055 New
66,055 $577,000

Others Institutions Holding JNCE

# of Institutions
4
Shares Held
720K
Call Options Held
0
Put Options Held
0
View Full List

About Jounce Therapeutics, Inc.

JNCE Quotes by TradingView
  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Systematic Financial Management LP Portfolio

Follow Systematic Financial Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email